114 related articles for article (PubMed ID: 6284190)
1. A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
Thomas GM; Rauth AM; Black BE; Cummings BJ; Sorenti VL; Bush RS
Br J Cancer; 1982 Jun; 45(6):860-8. PubMed ID: 6284190
[TBL] [Abstract][Full Text] [Related]
2. Misonidazole with dexamethasone rescue: an escalating dose toxicity study.
Tanasichuk H; Urtasun RC; Fulton DS; Raleigh J
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1735-7. PubMed ID: 6480455
[TBL] [Abstract][Full Text] [Related]
3. Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?
Nelson DF; Gillespie BW; Diener MD; Davis DR; Wasserman T; Phillips TL; Stetz J
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1731-4. PubMed ID: 6384162
[TBL] [Abstract][Full Text] [Related]
4. Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.
Bauer M; Leibel S; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Conner N; Pakuris E
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1101-3. PubMed ID: 3528087
[TBL] [Abstract][Full Text] [Related]
5. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix.
Overgaard J; Bentzen SM; Kolstad P; Kjoerstad K; Davy M; Bertelsen K; Mäntyla M; Frankendal B; Skryten A; Löftquist I
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1069-72. PubMed ID: 2649463
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
Leibel S; Bauer M; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Pakuris E; Conner N
Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):541-9. PubMed ID: 3104249
[TBL] [Abstract][Full Text] [Related]
7. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.
Urtasun RC; Tanasichuk H; Fulton D; Agboola O; Turner AR; Koziol D; Raleigh J
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):365-9. PubMed ID: 7107353
[TBL] [Abstract][Full Text] [Related]
8. The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.
Sheldon PW; Clarke C; Dawson KB
Br J Cancer; 1984 Feb; 49(2):207-13. PubMed ID: 6696821
[TBL] [Abstract][Full Text] [Related]
9. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
Eifel PJ; Brown DM; Lee WW; Brown JM
Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
[TBL] [Abstract][Full Text] [Related]
10. Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
Coleman CN; Wasserman TH; Urtasun RC; Halsey J; Noll L; Hancock S; Phillips TL
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):389-93. PubMed ID: 2154420
[TBL] [Abstract][Full Text] [Related]
11. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
12. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
Abratt RP; Sealy R; Tucker RD; Williams MA; Barnes DR; Johnson MB; Green JA; Cridland JS
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
Eifel PJ; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
[TBL] [Abstract][Full Text] [Related]
14. Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Phillips TL; Wasserman TH; Johnson RJ; Levin VA; VanRaalte G
Cancer; 1981 Oct; 48(8):1697-704. PubMed ID: 6269723
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
[TBL] [Abstract][Full Text] [Related]
16. Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
Coleman CN; Wasserman TH; Phillips TL; Strong JM; Urtasun RC; Schwade JG; Johnson RJ; Zagars G
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):371-5. PubMed ID: 7107354
[TBL] [Abstract][Full Text] [Related]
17. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
19. Radical irradiation and misonidazole in the treatment of advanced cervical carcinoma: results of a phase II trial.
Girinski T; Pejovic MH; Haie C; Bonnay M; Gerbaulet A; Mazeron JJ; Malaise E; Chassagne D
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1783-7. PubMed ID: 4044341
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule.
Coleman CN; Wasserman TH; Urtasun RC; Halsey J; Hirst VK; Hancock S; Phillips TL
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1105-8. PubMed ID: 3017904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
